Research Article

Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics

Figure 1

JGXZ treatment reduced body weight gain and improved liver steatosis in NAFLD model rats. (a) JGXZ treatment decreased the body weight in NAFLD model rats. (b) JGXZ treatment decreased the liver index in NAFLD model rats. (c) H&E staining indicated that JGXZ treatment ameliorated liver steatosis in NAFLD model rats (100 ×). (d, e) oil red O staining showed that after JGXZ treatment, the liver lipid content of NAFLD model rats decreased(100 ×). (f) JGXZ treatment decreased the levels of ALT, AST, TG, and TC in NAFLD model rat serum. Control, model, and JGXZ groups (n = 10 per group). Data are presented as the mean ± SD. # compared to the control group. ## compared to the control group. compared to the experimental model group. compared to the experimental model group.
(a)
(b)
(c)
(d)
(e)
(f)